COMPETITIONRX LTDActive
Key figures
COMPETITIONRX LTD does not disclose its turnover in its latest accounts; the profit for the year is as stated in the accounts.
Ratios
2024/25Balance sheet structure
Dividends
from the accountsDividends paid in the financial year: £550,000.
Filed accounts2019/20–2024/25
| 2020/21 | 2021/22 | 2022/23 | 2023/24 | 2024/25 | |
|---|---|---|---|---|---|
| Turnover | 15,167 | 47,210 | 56,637 | 0 | — |
| Profit for the year | -14,660 | 6,782 | 50,439 | 1,631 | 1,006 |
| Total assets | 1,434,591 | 1,544,905 | 1,468,256 | 1,460,653 | 1,462,646 |
| Total liabilities | 740,332 | 843,864 | 716,776 | 707,542 | 708,529 |
| Net assets / total equity | 694,259 | 701,041 | 751,480 | 753,111 | 754,117 |
| Average number of employees | 0 | 0 | 0 | 0 | 0 |
| Dividends paid | -550,000 | — | — | — | — |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Principal activity
Accounts 2025The principal activity of the Company was management consultancy.
As described in the company's latest filed accounts.
Summary: COMPETITIONRX LTD
Company
COMPETITIONRX LTD is a private limited company registered with Companies House under company number 07013718. It was incorporated on 9 Sep 2009. Its status is active. The registered office is in London (EC4M). Its nature of business (SIC 2007) is management consultancy activities other than financial management (70229).
Accounts
The latest accounts in the database are for 2024/25 (period ending 31 Aug 2025); the company files full accounts. Profit for the year was £1,006. Net assets were £754,117, up 0.1% on the previous year. Total assets were £1,462,646 and total liabilities £708,529. The company had an average of 0 employees. Figures are available for 6 financial years (2019/20–2024/25).
Control and charges
One person with significant control is registered.
Filing deadlines
The next accounts are due by 31 May 2027. The next confirmation statement is due by 14 Sep 2027.